Trials / Withdrawn
WithdrawnNCT01554020
Blood Sugar Take Care and Glucose Metabolism
Effect of Blood Sugar Take Care on Glucose Metabolism, Determinants of Metabolic Syndrome, and Quality of Life in Prediabetic Adults: A Randomized, Double-blind, Placebo-controlled Study
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- NewChapter, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This prospective international clinical trial is a two-arm, double-blind, randomized, placebo-controlled, parallel-group, multicenter study. 112 prediabetic subjects will be randomized to Blood Sugar Take Care or placebo. Randomization will be stratified by gender. The intervention period is 12 weeks. The primary outcome is fasting glucose levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Blood Sugar Take Care | One 1200 mg soft gel capsule administered 3X/day for duration of study |
| DIETARY_SUPPLEMENT | Placebo | One 1200 mg soft-gel capsule administered 3X/day for duration of study |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2013-10-01
- Completion
- 2013-11-01
- First posted
- 2012-03-14
- Last updated
- 2013-03-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01554020. Inclusion in this directory is not an endorsement.